Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis
European Journal of Dermatology, 05/05/09
Balci DD et al. - Non-classical superantigens such as methicillin resistance gene (mecA), see and etb may also be associated with psoriasis.
Related Articles
Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09
Relevance Score: 95%
FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09
Relevance Score: 91%
Study shows major burden of psoriasis
Internet Source, 10/29/09
Relevance Score: 91%
Prevalence of myocardial infarction in patients with psoriasis in central China
Journal of the European Academy of Dermatology and Venereology, 10/27/09
Relevance Score: 91%
Why nail psoriasis remains difficult to treat
Dermatology in Practice, 10/12/09
Relevance Score: 91%
Today in Derm Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
The 5-D itch scale: a new measure of pruritus
British Journal of Dermatology, 12/10/09
A novel human skin chamber model to study wound infection ex vivo
Archives of Dermatological Research, 12/09/09
Disseminated Herpes Zoster Mimicking Rheumatoid Vasculitis in a Rheumatoid Arthritis Patient on Etanercept
Dermatology, 12/08/09
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Comorbidities in Patients with Psoriasis
American Journal of Medicine, 12/09/09
Site of psoriasis (scalp or intergluteal/perianal), >=3 affected sites, and nail dystrophy predicted psoriatic arthritis in incident psoriasis
Evidence-Based Medicine, 12/08/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


